{"symbol":"CRM","provider":"yahoo-finance","fetchedAt":"2025-12-26T04:28:39.469Z","asOfDate":"2025-12-25","articles":[{"id":"dfe2cf3e-e725-3b42-ae89-dd5345e2ca3b","title":"E-Commerce Today - Emerging Opportunities in UK Online Retail Market","url":"https://finance.yahoo.com/news/e-commerce-today-emerging-opportunities-123721538.html","publisher":"Simply Wall St.","publishedAt":"2025-12-25T12:37:21.000Z","relatedTickers":["ADBE","AMZN"],"mainIdea":"E-Commerce Today - Emerging Opportunities in UK Online Retail Market","summary":"Simply Wall St.: E-Commerce Today - Emerging Opportunities in UK Online Retail Market. The UK online retail market continues to evolve with significant opportunities identified in health & beauty and online food & grocery sectors, which are appealing to budget-conscious consumers and benefiting from investments by grocers. The adoption of omnichannel strategies, including marketplace formats and click & collect services, is enhancing competitive positioning in the market. Recent reports indicate the online market's growth trajectory remains strong, with particular emphasis on... Related tickers mentioned: ADBE, AMZN."},{"id":"59c8c41f-e1b0-34d1-a798-938ede3a1661","title":"Novo, Lilly race to cement lead in India’s obesity drug market, Reuters says","url":"https://finance.yahoo.com/news/novo-lilly-race-cement-lead-114028860.html","publisher":"TipRanks","publishedAt":"2025-12-25T11:40:28.000Z","relatedTickers":["LLY","NONOF","NVO"],"mainIdea":"Novo, Lilly race to cement lead in India’s obesity drug market, Reuters says","summary":"TipRanks: Novo, Lilly race to cement lead in India’s obesity drug market, Reuters says. Eli Lilly (LLY) and Novo Nordisk (NVO) are racing to cement their lead in India’s obesity drug market before cheaper generic version enter stores in March, Rishika Sadam of Reuters reports. Novo’s strategy focuses on price cuts and accelerated launches while Lilly’s products benefitted from entering the market early. Both companies have outreached to doctors, advertised heavily, provided incentives to patients, and entered distribution deals with local drugmakers, doctors, analysis, and others i Related tickers mentioned: LLY, NONOF, NVO."},{"id":"8034aab4-6d21-3a7e-9e13-2cea6216ece6","title":"Restaurants, Weed, and Other Stock Themes On Our 2026 Radar","url":"https://finance.yahoo.com/m/8034aab4-6d21-3a7e-9e13-2cea6216ece6/restaurants%2C-weed%2C-and-other.html","publisher":"Barrons.com","publishedAt":"2025-12-25T08:12:00.000Z","relatedTickers":["AIQ","CURLF","DPZ","LZB","PM","^GSPC"],"mainIdea":"Restaurants, Weed, and Other Stock Themes On Our 2026 Radar","summary":"Barrons.com: Restaurants, Weed, and Other Stock Themes On Our 2026 Radar. As 2025 winds to a close, Barron’s Investor Circle reporters are, not unexpectedly, already staking out the investment landscape for 2026. Key drivers include a ramp-up of its Uber Eats and DoorDash presence and faster delivery times. Related tickers mentioned: AIQ, CURLF, DPZ, LZB, PM, ^GSPC."},{"id":"259f6d49-5500-32a2-bdf2-ec6de238cb7b","title":"Elon Musk Backs Demis Hassabis In Dispute With Meta's Yann LeCun Over 'General Intelligence,' Says Google DeepMind CEO Is 'Right'","url":"https://finance.yahoo.com/news/elon-musk-backs-demis-hassabis-213112960.html","publisher":"Benzinga","publishedAt":"2025-12-24T21:31:12.000Z","relatedTickers":["GOOG","META","TSLA"],"mainIdea":"Elon Musk Backs Demis Hassabis In Dispute With Meta's Yann LeCun Over 'General Intelligence,' Says Google DeepMind CEO Is 'Right'","summary":"Benzinga: Elon Musk Backs Demis Hassabis In Dispute With Meta's Yann LeCun Over 'General Intelligence,' Says Google DeepMind CEO Is 'Right'. On Monday, Tesla Inc. (NASDAQ:TSLA) CEO Elon Musk weighed in on an AI debate, siding with Alphabet Inc.'s (NASDAQ:GOOG) (NASDAQ:GOOGL) Google DeepMind CEO Demis Hassabis after Meta Platforms, Inc.'s (NASDAQ:META) outgoing AI chief Yann LeCun dismissed the idea of \"general intelligence\" as an illusion. Musk Weighs In On AGI Debate Musk amplified Hassabis' rebuttal to LeCun in a post on X, writing simply, \"Demis is right,\" throwing his support behind the DeepMind chief in a widening public dispute Related tickers mentioned: GOOG, META, TSLA."},{"id":"c40c62e1-2a05-3341-b072-3b8d8254886f","title":"This Tech Investor Likes Broadcom, Bloom Energy, and Other AI Bargains","url":"https://finance.yahoo.com/m/c40c62e1-2a05-3341-b072-3b8d8254886f/this-tech-investor-likes.html","publisher":"Barrons.com","publishedAt":"2025-12-24T19:36:00.000Z","relatedTickers":["AVGO","BE","CRWV","GEV","NVDA"],"mainIdea":"This Tech Investor Likes Broadcom, Bloom Energy, and Other AI Bargains","summary":"Barrons.com: This Tech Investor Likes Broadcom, Bloom Energy, and Other AI Bargains. Paul Wick of Seligman Investments has piloted his winning fund through numerous technology cycles. How he is playing AI, and why he is skeptical of quantum computing stocks. Related tickers mentioned: AVGO, BE, CRWV, GEV, NVDA."},{"id":"918ce0a7-6af2-35ca-9dbc-d89952c251d6","title":"3 Artificial Intelligence (AI) Trends to Watch in 2026 and How to Invest in Them","url":"https://finance.yahoo.com/m/918ce0a7-6af2-35ca-9dbc-d89952c251d6/3-artificial-intelligence.html","publisher":"Motley Fool","publishedAt":"2025-12-24T16:05:00.000Z","relatedTickers":[],"mainIdea":"3 Artificial Intelligence (AI) Trends to Watch in 2026 and How to Invest in Them","summary":"Motley Fool: 3 Artificial Intelligence (AI) Trends to Watch in 2026 and How to Invest in Them. AI is constantly evolving, and these companies will continue to push it forward in 2026."}]}
